162 related articles for article (PubMed ID: 21499794)
1. Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world.
Safren SA; Hendriksen ES; Smeaton L; Celentano DD; Hosseinipour MC; Barnett R; Guanira J; Flanigan T; Kumarasamy N; Klingman K; Campbell T
AIDS Behav; 2012 Feb; 16(2):266-77. PubMed ID: 21499794
[TBL] [Abstract][Full Text] [Related]
2. Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings.
Torres TS; Harrison LJ; La Rosa AM; Lavenberg JA; Zheng L; Safren SA; Ngongondo M; Poongulali S; Matoga M; Samaneka W; Collier AC; Hughes MD
AIDS Care; 2018 Aug; 30(8):954-962. PubMed ID: 29343078
[TBL] [Abstract][Full Text] [Related]
3. Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.
Grinsztejn B; Smeaton L; Barnett R; Klingman K; Hakim J; Flanigan T; Kumarasamy N; Campbell T; Currier J;
Antivir Ther; 2011; 16(7):1057-62. PubMed ID: 22024521
[TBL] [Abstract][Full Text] [Related]
4. Impact of antiretroviral therapy on health-related quality of life among South African women in the CAPRISA 002 acute infection study.
Tomita A; Garrett N; Werner L; Burns JK; Ngcobo N; Zuma N; Mlisana K; van Loggerenberg F; Abdool Karim SS
AIDS Behav; 2014 Sep; 18(9):1801-7. PubMed ID: 24849623
[TBL] [Abstract][Full Text] [Related]
5. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M
AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas.
Firnhaber C; Smeaton L; Saukila N; Flanigan T; Gangakhedkar R; Kumwenda J; La Rosa A; Kumarasamy N; De Gruttola V; Hakim JG; Campbell TB
Int J Infect Dis; 2010 Dec; 14(12):e1088-92. PubMed ID: 20961784
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age.
Sauvageot D; Schaefer M; Olson D; Pujades-Rodriguez M; O'Brien DP
Pediatrics; 2010 May; 125(5):e1039-47. PubMed ID: 20385636
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life dynamics of HIV-positive South African women up to ART initiation: evidence from the CAPRISA 002 acute infection cohort study.
Tomita A; Garrett N; Werner L; Burns JK; Mpanza L; Mlisana K; van Loggerenberg F; Abdool Karim SS
AIDS Behav; 2014 Jun; 18(6):1114-23. PubMed ID: 24368630
[TBL] [Abstract][Full Text] [Related]
9. Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.
Koller M; Fatti G; Chi BH; Keiser O; Hoffmann CJ; Wood R; Prozesky H; Stinson K; Giddy J; Mutevedzi P; Fox MP; Law M; Boulle A; Egger M
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):e110-9. PubMed ID: 26470034
[TBL] [Abstract][Full Text] [Related]
10. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.
Tuboi SH; Brinkhof MW; Egger M; Stone RA; Braitstein P; Nash D; Sprinz E; Dabis F; Harrison LH; Schechter M
J Acquir Immune Defic Syndr; 2007 May; 45(1):52-9. PubMed ID: 17460471
[TBL] [Abstract][Full Text] [Related]
11. Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions.
Yehia BR; Long JA; Stearns CR; French B; Tebas P; Frank I
AIDS Care; 2012; 24(6):769-77. PubMed ID: 22106980
[TBL] [Abstract][Full Text] [Related]
12. Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe.
Patel R; Kassaye S; Gore-Felton C; Wyshak G; Kadzirange G; Woelk G; Katzenstein D
AIDS Care; 2009 Dec; 21(12):1517-27. PubMed ID: 20024731
[TBL] [Abstract][Full Text] [Related]
13. Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.
Tuboi SH; Pacheco AG; Harrison LH; Stone RA; May M; Brinkhof MW; Dabis F; Egger M; Nash D; Bangsberg D; Braitstein P; Yiannoutsos CT; Wood R; Sprinz E; Schechter M;
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):70-7. PubMed ID: 20035163
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
[TBL] [Abstract][Full Text] [Related]
15. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH;
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149
[TBL] [Abstract][Full Text] [Related]
16. Changes health-related quality of life in HIV-infected patients following initiation of antiretroviral therapy: a longitudinal study.
Dutra BS; Lédo AP; Lins-Kusterer L; Luz E; Prieto IR; Brites C
Braz J Infect Dis; 2019; 23(4):211-217. PubMed ID: 31344351
[TBL] [Abstract][Full Text] [Related]
17. The effect of community-based support services on clinical efficacy and health-related quality of life in HIV/AIDS patients in resource-limited settings in sub-Saharan Africa.
Kabore I; Bloem J; Etheredge G; Obiero W; Wanless S; Doykos P; Ntsekhe P; Mtshali N; Afrikaner E; Sayed R; Bostwelelo J; Hani A; Moshabesha T; Kalaka A; Mameja J; Zwane N; Shongwe N; Mtshali P; Mohr B; Smuts A; Tiam A
AIDS Patient Care STDS; 2010 Sep; 24(9):581-94. PubMed ID: 20799894
[TBL] [Abstract][Full Text] [Related]
18. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.
Robertson K; Kumwenda J; Supparatpinyo K; Jiang JH; Evans S; Campbell TB; Price RW; Murphy R; Hall C; Marra CM; Marcus C; Berzins B; Masih R; Santos B; Silva MT; Kumarasamy N; Walawander A; Nair A; Tripathy S; Kanyama C; Hosseinipour M; Montano S; La Rosa A; Amod F; Sanne I; Firnhaber C; Hakim J; Brouwers P;
J Neurovirol; 2011 Oct; 17(5):438-47. PubMed ID: 21786076
[TBL] [Abstract][Full Text] [Related]
19. Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection.
Lifson AR; Grund B; Gardner EM; Kaplan R; Denning E; Engen N; Carey CL; Chen F; Dao S; Florence E; Sanz J; Emery S;
AIDS; 2017 Apr; 31(7):953-963. PubMed ID: 28121710
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
